In the press
New Podcast Launched
We are ecstatic to announce that we have launched our new podcast “OGB Podcast” on both Spotify and Anchor.
We will be talking to industry leaders about the state of the biotech industry as well as delving into the specifics of our guests expertise. You can find and listen to us on Spotify ( https://open.spotify.com/show/0tSRtB4tFUcqHhW43RkWIL ) as well as Anchor ( https://anchor.fm/marc-appel9 ).
Related Press
Genexys BioMed Awarded $320K SBIR Grant to Advance Novel Cystic Fibrosis Gene Therapy
NIH Grant to Accelerate Development of Innovative Non-Viral, Non-Lipid Platform Originating from Cincinnati Children’s CINCINNATI, Ohio, July 30, 2024 — Genexys BioMed, a pre-clinical stage biotechnology company developing a novel non-viral, non-lipid genetic medicine platform for the treatment of cystic fibrosis (CF) and other genetic diseases, announced today it has been awarded a $320,000 Phase
Orange Grove Bio and University of Chicago Form Strategic Partnership to Accelerate Biotech Innovation and Commercialization
Collaboration Aims to Bridge the Gap Between Academic Research and Commercial Development, Fostering a Thriving Biotech Ecosystem in Chicago CINCINNATI, Ohio, July 23, 2024 — Orange Grove Bio, a leading integrated biopharmaceutical company, and the University of Chicago’s Polsky Center for Entrepreneurship and Innovation today announced a strategic partnership to catalyze the successful commercialization of
Orange Grove Bio Subsidiary Awarded $2.05 Million SBIR Phase II Grant to Advance Development of Novel Platelet Preservation Technology
OGB Also Announces Key Appointments to Board of Senior Advisors and the Opening of New Headquarters The following excerpt was taken from GlobeNewswire – continue reading here. CINCINNATI, Sept. 28, 2023 (GLOBE NEWSWIRE) Orange Grove Bio (OGB), a drug investment and development firm, today announced that Preservation Bio, one of the firm’s majority-owned subsidiaries, has been
Orange Grove Bio and Cincinnati Children’s Hospital Medical Center Establish Collaboration
Orange Grove Bio, a preclinical drug investment and development firm, and Cincinnati
Research Bridge Partners’ Seed Capital Investment in Asalyxa Bio
Research Bridge Partners’ Seed Capital Investment in Asalyxa Bio The following was taken from PR Newswire and you can read it here: https://www.prnewswire.com/news-releases/research-bridge-partners-seed-capital-investment-in-asalyxa-bio-advances-dr-lola-eniola-adefesos-immune-cell-targeted-therapeutic-platform-301242853.html “Research Bridge Partners – a 501 (c) (3) organization that bridges preeminent innovators at mid-continent research universities AUSTIN, Texas, March 9, 2021 /PRNewswire/ — Research Bridge Partners – a 501 (c) (3)
Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships
Collaborations with Yonsei University Health System and Pohang University of Science and Technology Designed to Strengthen Biotech Entrepreneurial Ecosystem in South Korea The following excerpt was taken from Globenewswire– continue reading here. Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships CINCINNATI, March 23, 2023 (GLOBE NEWSWIRE) — Orange Grove Bio, a
Orange Grove Bio Appoints Key Leadership & New Academic Collaboration
The University of Pittsburgh and Orange Grove Bio Establish Partnership… The following excerpt was taken from Globe Newswire — continue reading here. Orange Grove Bio, a preclinical drug investment and development firm, today announced several key leadership appointments highlighted by its naming John C. Byrd, M.D. Orange Grove Bio, a preclinical drug investment and development
Magnuson Center for Entrepreneurship at Dartmouth College and Orange Grove Bio Establish Collaboration
Magnuson Center for Entrepreneurship at Dartmouth College and Orange Grove Bio Establish Collaboration to Strengthen Biotech Ecosystem and Support Development and Commercialization of Novel Therapeutics The following excerpt was taken from Globenewswire– continue reading here. Orange Grove Bio, a drug investment and development firm, today announced the establishment of a strategic collaboration with the Magnuson
1819 Innovation Hub tenant inks key partnership with Korea VC firm
1819 Innovation Hub tenant inks key partnership with Korea VC firm The following excerpt was taken from TechOhio– continue reading here. A biotech firm that moved its headquarters from New York to Cincinnati in late 2021 has announced its first major collaboration A biotech firm that moved its headquarters from New York to Cincinnati in